Portfolio news - Archive
19.12.2008 NeurogesX Announces FDA Acceptance to Review New Drug Application for NGX-4010 to Treat Post-Herpetic Neuralgia 
more...
12.12.2008 Agendia’s MammaPrint® Predicts to Neoadjuvant Chemotherapy in Breast Cancer
more...
09.12.2008 CombinatoRx Presents New Data on B-Cell Malignancy Programs
more...
27.11.2008 MediGene: European Patent Office decides to grant new European Patent for Veregen®
more...
22.10.2008 NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
more...
20.10.2008 MediGene Reports Positive Final Results from EndoTAG(TM)-1 Phase II Study in Pancreatic Cancer
more...
17.10.2008 Medigene: RhuDex(TM) to be Examined in Further Laboratory Tests
more...
15.10.2008 New class of drug candidates developed by Santaris Pharma can potently counteract disease-associated microRNAs
more...
01.10.2008 MediGene Spins Out mTCR Programme - Independent Company Immunocore Limited Founded
more...
29.09.2008 Nitec Pharma AG secures funding of CHF 24M from TVM and Deutsche Bank
more...
29.09.2008 Medigene Clinical data for EndoTAG(TM)-1 to be presented at two further medical conferences (DVGS, UEGW)
more...
21.09.2008 Coapt Sytems Launches FDA Cleared Novielle Voice(TM) For Restoration Of Voice Loss
more...
16.09.2008 MediGene reports positive 12-month survival data for EndoTAG(TM)-1 from Phase II pancreatic cancer study 
more...
15.09.2008 Medigene Appoints Dr Hans Joachim Bochtler as Vice President Clinical Research & Development
more...
09.09.2008 New clinical data for EndoTAG(TM)-1 to be presented at
more...
04.09.2008 Agendia Launches TargetPrint© for Breast Cancer Patients
more...
02.09.2008 Fibrex Medical Reports Positive Phase II Results for FX06
more...
02.09.2008 7TM Pharma has initiated Phase I/IIa clinical trial with TM30339 for the treatment of obesity and related metabolic disorders
more...
19.08.2008 European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
more...
31.07.2008 MediGene Sells Licensee Rights to the Drug Oracea® to Galderma
more...
16.07.2008 Wacker validates scalability of Anticalin® production with E.coli secretion technology and will produce Pieris first clinical candidate PRS-050
more...
27.06.2008 Action Pharma presents pre-clinical data for treatment of Type 2 diabetes
more...
25.06.2008 Action Pharma launches a Phase II clinical trial more...
24.06.2008 MediGene Achieves Positive Results with RhuDex® in Clinical Phase IIa Trial more...
24.06.2008 FierceBiotech Names Santaris Pharma as One of the "Fierce 15" Biotech Companies of 2008 more...
18.06.2008Santaris Pharma appoints Søren Tulstrup as new President & CEO
more...
12.06.2008 Nitec to present Lodotra™ 12 month treatment data in Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR) in Paris
more...
10.06.2008 IMI Intelligent Medical Implants AG announces the appointment of Dr. Stephen J McCormack as Chief Executive Officer more...
13.05.2008 Intercell AG to acquire Iomai Corporation to expand late stage product pipeline and strengthen leadership in vaccine innovation
more...
24.04.2008 European Regulatory Authority (EMEA) Recommends Granting of Marketing Authorization for MediGene's Drug Oracea®
more...
24.04.2008 Intercell was awarded "The Vaccine Industry Excellence Award" in the category "Best New Therapeutic Vaccine" for its therapeutic Hepatitis C (HCV) vaccine candidate more...
21.04.2008 Intercell - Strong alliance to fight fungal infections more...
16.04.2008 7TM Pharma receives milestone payment from asthma and allergy collaboration more...
16.04.2008 Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education more...
15.04.2008 Intercell's investigational vaccine against Japanese Encephalitis shows excellent safety and immunogenicity in Phase II trials in children more...
07.04.2008 MediGene Presents Details of the Excellent Clinical Efficacy Data Obtained with EndoTAG(TM)-1 in the Indication Pancreatic Carcinoma more...
02.04.2008 MediGene Extends Protection for its Innovative EndoTAG(TM) Technology by Another European Patent more...
27.03.2008 Pieris raises € 25 M (US$ 38 M) in Series B financing round more...
12.03.2008 CombinatoRx Drug Candidate CRx-191 Demonstrates Positive Phase 2 Results in Psoriasis more...
10.03.2008 7TM Pharma enters into drug discovery collaboration with Dr. Reddy’s on selected drug targets more...
03.03.2008 FIRST PROFITABLE YEAR IN INTERCELL'S HISTORY – CLEAR GROWTH IN REVENUES AND PROFITABILITY EXPECTED FOR 2008 more...
29.02.2008 Licensure application for JE vaccine submitted to Therapeutic Goods Administration in Australia more...
06.02.2008 7TM Pharma announces the selection of a new pre-clinical development candidate, TM38837, for treatment of obesity and Type 2 diabetes more...
26.01.2008 Blind patients see the light with retinal implant system from Switzerland's IMI more...
17.01.2008 Action Pharma raises EUR 15 million from investors more...
19.12.2007 GlaxoSmithKline and Santaris Pharma enter global R&D alliance to discover, develop and commercialise RNA antagonists as novel antivirals more...
18.12.2007 Santaris raises €20 million of new equity more...
16.12.2007 Intercell Receives Milestone Payment From Merck & Co. Inc Triggered By Initiation Of Phase II Clinical Trial of Investigational Vaccine to Prevent S.aureus Infection more...
06.12.2007 Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Encephalitis Vaccine more...
04.12.2007 SSI, Intercell and Areas announce start of clinical trial for novel vaccine candidate against TB more...
03.12.2007 Intercell´s clinical data on Japanese Encephalitis vaccine published in “The Lancet” more...
19.11.2007 Agendia B.V.; Time "Best Inventions Of 2007" Cancer's Crystal Ball
(page 61) more...
16.11.2007 Pfizer to Acquire Coley Pharmaceutical Group more...
30.10.2007 Pieris and Pepscan to identify GPCR-specific Anticalins® using CLIPS™ protein mimicry technology more...
09.10.2007 NeurogesX Expands Senior Management Team more...
10.09.2007 MediGene Raises € 15,6 Million in Private Placement with Santo Holding GmbH more...
05.09.2007 MediGene Completes Patient Recruitment for Clinical Trial of Cancer-Killing Virus NV1020 more...
05.09.2007 Pieris validates the use of Anticalins® as ophtalmologic biotherapeutics more...
04.09.2007 NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia more...
31.08.2007 MediGene: European Approval Procedure for the Six-Months Dosage of Cancer Drug Eligard® Successfully Completed more...
28.08.2007 Agendia BV raises €25 Million ($34M) and Receives Second FDA Clearance more...
21.08.2007 Intercell’s therapeutic Hepatitis C vaccine meets primary endpoints in Phase II interim analys more...
16.07.2007 First child vaccinated with Intercell Japanese Encephalitis (JE) Vaccine in India - Pediatric Phase II clinical trial started more...
10.07.2007 Pieris progresses proprietary asthma program: validation of pulmonary delivery of Anticalin® -based protein product candidate more...
10.07.2007 Agendia BV; Gene expression profile determines prognosis of stage II colon cancer patients more...
04.07.2007 Santaris Pharma consortium awarded E1.35m by Denmark's Advanced Technology Foundation for development of the first microRNA medicine more...
02.07.2007 Intercell and Novartis form world-leading strategic partnership to drive vaccines innovation more...
07.06.2007 7TM Pharma raises DKK 123 million in financing round more...
30.06.2007 CombinatoRx - Old Drugs In, New Ones Out more...
21.05.2007 CombinatoRx Has a Rich Pipeline more...
18.05.2007 Intercell AG; Staphylococcus aureus vaccine development on track - safe and immunogenic in Phase I clinical trials more...
25.04.2007 Cytos enters exclusive license agreement with Novartis to develop, manufacture and commercialize novel vaccine for treatment of nicotine addiction
more...
17.04.2007 Santaris Pharma presents positive preclinical data on SPC 2996 at the American Association for Cancer Research more...
29.03.2007 Pieris demonstrates potent anti-tumor activity of a VEGF-specific Anticalin® in preclinical studies more...
26.01.2007 Agendia's MammaPrint® breast cancer prognosis test cleared by U.S. Food and Drug Administration (FDA) more...
26.01.2007 FDA approves Enzon IND for Santaris Pharma’s Second New Cancer Drug Company receives $5m milestone payment from Enzon Pharmaceuticals more...
23.01.2007 Dr Walter Wenninger appointed to Santaris Pharma Board more...
28.11.2006 Santaris Pharma awarded Ernst&Young Entrepreneur of the Year 2006 more...
25.10.2006 Pieris confirms in vivo activity pf potent VEGF-specific Anticalin® more...
18.10.2006 NeurogesX Phase 3 Study in Post-Herpetic Neuralgia Meets Primary Endpoint more...
13.10.2006 Intercell AG wins European Biotechnica Award 2006 more...
12.10.2006 Claus Braestrup, CEO of Lundbeck, appointed to Santaris Pharma Board more...
28.09.2006 Nitec Pharma Reports Positive Phase III Results and Filing in EU for LODOTRA(tm) more...
06.09.2006 Agendia's MammaPrint® breast cancer prognosis test validated by an independent international consortium more...
27.07.2006 Enzon and Santaris Pharma enter into Global Collaboration to Develop Novel Cancer Therapeutics more...
31.05.2006 Positive results for Intercell's Japanese Encephalitis virus vaccine in pivotal clinical trail more...
24.03.2006 CombinatoRx Reports Positive Results for CRx-170 in Phase 2 Proof-of-Concept Asthma Clinical Trial; Novel Combination Drug Candidate Demonstrates Clinical Benefit on Forced Expiratory Volume (FEV1) more...
24.03.2006 CombinatoRx Announces Closing of $48.0 Million Private Placement more...
21.03.2006 Coley Pharmaceutical Group Announces Top-line Data from a Clinical Study of Actilon(tm) for Hepatitis C more...
31.01.2006 Cyberkinetics Provides Update on Braingate (TM) System Pilot Clinical Trials: Total of Four Participants Have Enrolled in Ongoing Trials of BrainGate System
more...
31.01.2006 Orphan Drug Status for Intercell's JEV Vaccine more...
30.01.2006 CombinatoRx Drug Candidate CRx-102 Demonstrates Positive Phase 2 Study Results in Hand Osteoarthritis more...
03.10.2005 CombinatorX and Angiotech sign agreement to apply CombinatorX's pipeline and technology to the field of interventional medicines more...
09.08.2005 Intercell AG - Start of Phase III clinical trials for Japanese Encephalitis Vaccine now approved by major European authorities - EMEA supports Intercell's Clinical Development Strategy more...
01.08.2005 Coley Pharmaceutical Group Sets Price for Public
Offering more...
14.06.2005 $ 6.6 million R&D grant from US NIH for
Intercell to develop biodefense
vaccines more...
09.06.2005 Robert L. Bratzler, CEO of Coley Pharmaceutical
Group, Honored with The
Oliver R. Grace Award by the Cancer Research
Institute more...
14.05.2005 Cytos AG - Vaccine to treat nicotine addiction
achieves proof of efficacy more...
20.04.2005 Coley Pharmaceutical Group Files Registration Statement for
Proposed Initial Public Offering more...
12.04.2005 Pieris Proteolab AG und Syngenta Biopharma Collaborate to Develop
Anticalins more...
04.04.2005 Cyberkinetics Gives Update on BrainGate Clinical Trial more...
04.04.2005 Cyberkinetics Receives Neuropart 510K Clearance; Acute Neural Monitor is Company's First Commercial Clinical Product more...
01.04.2005 Cytos Biotechnology and Medarex expand their collaboration for new drug targets more...
02.03.2005 Intercell Shares begin trading on the Vienna Stock Exchange more...
01.02.2005 Die Schweizer Glycart Biotechnology AG verbessert die Wirksamkeit von therapeutischen Antikörpern more...
13.12.2004 CombinatorX files registration statement for proposed initial public offering more...
13.12.2004 Intercell AG and SciGen Ltd. sign an exclusive agreement for the development of a therapeutic Hepatitis B vaccine more...
07.12.2004 MediGene Successfully Completes Pivotal Clinical Phase II Trials of Polypehnon® Ointment for the Treatment of Genital Warts more...
02.12.2004 Cytos Biotechnology announces change in Executive Board more...
02.12.2004 Coley Pharmaceutical GmbH Receives Award at the Future Congress 2004 "Benchmark NRW" more...
02.12.2004 Cytos Biotechnology initiates a phase II clinical trial with its Immunodrug™ candidate CYT005-AllQbG10 for treatment of allergy more...
26.10.2004 Xantos Biomedicine signs service agreement with Serono more...
07.10.2004 Cyberkinetics Neurotechnology Systems, Inc. completes merger, name change and reincorporates in Delaware more...
28.09.2004 Coley Pharmaceutical Group Raises $25 Million in Private Financing more...
21.09.2004 Cytos Biotechnology awarded the third prize of the European BioTechnica Award 2004 more...
21.09.2004 Coley Pharmaceutical Group Announces $16.9 Million Research Contract From NIH for Development of New Vaccine Adjuvants for Biodefense more...
16.09.2004 Clinical Trial advances Cytos Biotechnology's second Immunodrug™ platform more...
15.09.2004 Prof. Arne Skerra, Dr. Martin Pöhlchen, and Dr. Steffen Schlehuber Nominated for the German Future Prize (Deutscher Zukunftspreis) 2004 of the German Federal President more...
13.09.2004 Xantos secures additional finance of Euro 4 million (USD 4.8 million) more...
02.09.2004 Xantos Biomedicine integrates Evotec Technologies high content imaging reader OperaTM into its cDNA transfection technology XantosScreenTM more...
31.08.2004 Intercell AG Announces Extended Collaboration with Aventis on the Development of Bacterial Vaccines more...
28.07.2004 Cyberkinetics named among top 15 emerging Life Science Companies of 2004 more...
20.07.2004 Intercell reaches primary endpoint in successful Phase II Hepatitis C trial more...
23.06.2004 Intercell AG and Solvo Biotechnology Inc. Sign Licence Agreement more...
24.05.2004 Applied Phenomics enters collaboration with Xantos Biomedicine in histology-based target validation more...
17.05.2004 Develogen AG and Peptor Ltd shareholders approve
merger more...
07.05.2004 PIERIS receives € 2 million grant from German Ministry of Education and Research (BMBF) more...
28.04.2004 Glycart Biotechnology Appoints William J. Jenkins to Board of Directors more...
17.03.2004 Intercell and Statens Serum Institut Sign Cooperation and License Agreement to Develop Tuberculosis Vaccine more...
10.03.2004 CombinatorX raises $30 million in third Venture Capital Round more...
09.03.2004 Genencor Chairman Joins NeurogesX Board more...
03.03.2004 Intercell Acquires Manufacturing Plant in Scotland more...
17.02.2004 Aventis and Intercell sign collaboration and licence agreement to develop bacterial vaccines more...
17.02.2004 Exelixis Publishes World’s Most Comprehensive Collection of Functional Gene Knockouts in an Multicellular Organism more...
09.02.2004 Roche and Xantos Biomedicine AG sign agreement for compound-target validation more...
17.02.2004 Aventis and Intercell sign collaboration and licence agreement to develop bacterial vaccines more...
17.02.2004 Exelixis Publishes World’s Most Comprehensive Collection of Functional Gene Knockouts in an Multicellular Organism more...
09.02.2004 Roche and Xantos Biomedicine AG sign agreement for compound-target validation more...
09.02.2004 ARTEMIS Pharmaceuticals and AVENTIS Pharma R&D Sign Agreements Related to Mouse Genetics more...
03.02.2004 Cytos enters agreement to supply Alzheimer’s ImmunodrugTM candidate for early clinical development studies more...
22.01.2004 Sequenom collaborates with Health Protection Agency to apply MASSARRAY ™ Technology in Pathogen analysis more...
13.01.2004 Coley Pharmaceutical Group initiates phase 1 clinical trials of Actilon TM for chronic hepatitis C infection more...
07.01.2004 Cyberkinetics announces management additions in clinical operations and applications development more...
23.12.2003 Memory Pharmaceuticals Corp. files Registration Statement for Initial Public Offering of common stock more...
23.12.2003 AXXIMA appoints Yoram Karmon as new president and CEO more...
26.11.2003 Glycart Biotechnology closes $ 313.6m private financing round more...
18.11.2003 Pieris announces breakthrough in AnticalinR Technology more...
13.11.2003 Peptor and Develogen announce intentions to merge more...
27.10.2003 Healthgate completes acquisition of EBM Solutions,
Inc more...
20.08.2003 Apovia announces exclusive licence for otitis media vaccine from National Institute of Health more...
18.09.2003 Roche and Memory Expand Strategic Alliance in CNS more...
10.09.2003 Novartis executes Commercial Licence Agreement for Immunodrugs TM against neurodegenerative disease more...
10.09.2003 Develogen and Evotec OAI announce a strategic drug discovery and development alliance for metabolic deseases. more...
02.09.2003 Collaboration Agreement between Corixa and Apovia AG more...
01.09.2003 Coley Pharmaceutical Group Announces $35 Million Private Financing more...
17.07.2003 Intercell AG Vienna raises $34 million
10.07.2003 SEQUENOM announces genetic discovery collaboration with Bristol-Myers Squibb more...
09.07.2003 Cyberkinetics, Inc. raises $4.3 million to develop its Braingate neural interface device more...
01.07.2003 Cytos’ Immunodrug for smoking addiction successfully completes phase I clinical trial
06.05.2003 Exelixis Announces Departure of Chief Financial Officer more...
28.04.2003 Cytos and Novartis extend collaboration agreements
28.04.2003 SEQUENOM Customers Develop Two Novel Applications for MassARRAY(TM) Platform
23.04.2003 Cytos Immunodrug™ for smoking addiction enters phase I clinical trial
10.04.2003 DeveloGen AG und das Max-Planck-Institut für biophysikalische Chemie erhalten den Kooperationspreis des Landes Niedersachsen 2002
02.04.2003 SEQUENOM and Isis Pharmaceuticals Collaborate to Discover Genetic Variation in Antisense Drug Target Regions
31.03.2003 Exelixis Files IND for First Proprietary Anticancer Compound more...
06.03.2003 SEQUENOM Publishes Gene Expression Analysis Method
03.03.2003 Memory Pharmaceuticals compound MEM1414 to be developed by Roche for
treatment of Alzheimer's disease more...
17.02.2003 EBM Solutions, Inc. acquires Help4Life, Inc. more...
13.02.2003 Coley Pharmaceutical Group's CpG 7909 Active in Immunocompromised Patients more...
21.01.2003 Coley Pharmaceutical Group Receives Milestone Payment From Aventis Pharma more...
17.01.2003 DeveloGen and Scientists from IPK Gatersleben Publish Data on Key Trigger for Regenerating Insulin Producing Cells
15.01.2003 Xantos Biomedicine AG appoints Ulrich Brinkmann as Chief Scientific Officer
14.01.2003 SEQUENOM Adds Former Amgen President and COO Harry Hixson to Board of Directors
09.12.2002 Axxima receives one million Euro in funding from the BMBF "Proteomics" program more...
02.12.2002 Axxima founder Axel Ullrich awarded King Faisal International Prize worth 200,000 US dollars more...
31.10.2003 PIERIS Proteolab AG closes €12 million Financing Round
08.10.2002 Xantos Biomedicine AG Expands Its High Quality Full Length Human cDNA
Collection - Target identification and validation is greatly accelerated more...
03.10.2002 Health Net, Inc. (NYSE:HNT) announced today that it has partnered with EBM Solutions, Inc., a leading provider of evidence-based guidelines and care management applications, to provide its contracted physicians and health plan members with evidence-based resources regarding health care options and treatment plans
01.10.2002 Xantos Biomedicine AG announces the appointment of David Chilvers as Chief Business Officer - Paul Nicholson joins Board as Chairman more...
19.09.2002 COMBINATORx RAISES $40 MILLION
16.09.2002 APOVIA initiates MalariVax™ Phase I clinical trials - Clinical Trials for Malaria Vaccine start at the University of Maryland and in South Wales, UK more...
03.09.2002 DeveloGen appoints Dr. Klaus Brandau as Chairman of the Supervisory Board
26.08.2002 MyDocOnline Provides EBMSolutions' Application To Enhance Patient-Physician Communication more...
22.07.2002 BioFocus and Axxima enter Drug Discovery Collaboration more...
10.06.2002 ARTEMIS Pharmaceuticals and MERCK collaborate to develop customized mouse models. more...
23.04.2002 CombinatorX and SOSEI launch colloboration
22.04.2002 APOVIA raises € 19 Million in Private Financing Round - New Appointments to Supervisory Board more...
17.04.2002 DeveloGen Names Dr. Guenther Karmann as CEO
< back